Crossref
An Integrated Microfluidic CRISPR-Cas12a Platform for Robust POCT of Mycoplasma pneumoniae
BME Frontiers · 16.11.2026
DOI: 10.34133/bmef.0348 ↗Kurz gefasst
Fachartikel in der Zeitschrift BME Frontiers, online erschienen am 16.11.2026. Verfasst von Chang He und 12 weiteren Autor:innen.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
He, C., Luo, H., Liu, C., Liu, S., Luo, X., Loutfy, S. A., Erdem, A., Shin, M., Abe, H., Choi, J., Gong, B., Liu, S., & Li, C. (2026). An Integrated Microfluidic CRISPR-Cas12a Platform for Robust POCT of Mycoplasma pneumoniae. BME Frontiers. https://doi.org/10.34133/bmef.0348
Vancouver
He C, Luo H, Liu C, Liu S, Luo X, Loutfy SA, et al. An Integrated Microfluidic CRISPR-Cas12a Platform for Robust POCT of Mycoplasma pneumoniae. BME Frontiers. 2026. doi:10.34133/bmef.0348
BibTeX
@article{He2026,
author = {He, Chang and Luo, Hongzhi and Liu, Can and Liu, Shixu and Luo, Xiao and Loutfy, Samah A. and Erdem, Arzum and Shin, Minkyu and Abe, Hiroya and Choi, Jeong-Woo and Gong, Bo and Liu, Shan and Li, Chenzhong},
title = {An Integrated Microfluidic CRISPR-Cas12a Platform for Robust POCT of Mycoplasma pneumoniae},
journal = {BME Frontiers},
year = {2026},
doi = {10.34133/bmef.0348}
}
EUVIMED